Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation
- PMID: 37139784
- DOI: 10.1002/biof.1949
Reactive oxygen species produced by myeloid cells in psoriasis as a potential biofactor contributing to the development of vascular inflammation
Abstract
Psoriasis is an immune-mediated inflammatory skin disease driven by interleukin-17A (IL-17A) and associated with cardiovascular dysfunction. We used a severe psoriasis mouse model of keratinocyte IL-17A overexpression (K14-IL-17Aind/+ , IL-17Aind/+ control mice) to investigate the activity of neutrophils and a potential cellular interconnection between skin and vasculature. Levels of dermal reactive oxygen species (ROS) and their release by neutrophils were measured by lucigenin-/luminol-based assays, respectively. Quantitative RT-PCR determined neutrophilic activity and inflammation-related markers in skin and aorta. To track skin-derived immune cells, we used PhAM-K14-IL-17Aind/+ mice allowing us to mark all cells in the skin by photoconversion of a fluorescent protein to analyze their migration into spleen, aorta, and lymph nodes by flow cytometry. Compared to controls, K14-IL-17Aind/+ mice exhibited elevated ROS levels in the skin and a higher neutrophilic oxidative burst accompanied by the upregulation of several activation markers. In line with these results psoriatic mice displayed elevated expression of genes involved in neutrophil migration (e.g., Cxcl2 and S100a9) in skin and aorta. However, no direct immune cell migration from the psoriatic skin into the aortic vessel wall was observed. Neutrophils of psoriatic mice showed an activated phenotype, but no direct cellular migration from the skin to the vasculature was observed. This suggests that highly active vasculature-invading neutrophils must originate directly from the bone marrow. Hence, the skin-vasculature crosstalk in psoriasis is most likely based on the systemic effects of the autoimmune skin disease, emphasizing the importance of a systemic therapeutic approach for psoriasis patients.
Keywords: interleukin-17A; neutrophil granulocytes; psoriasis; reactive oxygen species.
© 2023 The Authors. BioFactors published by Wiley Periodicals LLC on behalf of International Union of Biochemistry and Molecular Biology.
References
REFERENCES
-
- Lowes MA, Suarez-Farinas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227-55.
-
- Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker J. Psoriasis. Psoriasis Lancet. 2021;397:1301-15.
-
- Global Burden of Disease Collaborative Network. Global burden of disease study 2010 (GBD 2010) results by cause 1990-2010. Seattle, WA: Institute for Health Metrics and Evaluation (IHME); 2012.
-
- Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol. 2014;134:1527-34.
-
- Bocheńska K, Smolińska E, Moskot M, Jakóbkiewicz-Banecka J, Gabig-Cimińska M. Models in the research process of psoriasis. Int J Mol Sci. 2017;18:2514.
MeSH terms
Substances
Grants and funding
- Boehringer Ingelheim Stiftung
- BMBF 01EO1503/Bundesministerium für Bildung und Forschung
- BMBF EDU-V24/Bundesministerium für Bildung und Forschung
- KA 4035/1-1/Deutsche Forschungsgemeinschaft
- Deutsche Herzstiftung
- TRR156/2(ID246807620)/DFG
- SFB1054(ID210592381)/DFG
- TRR128(ID213904703)/DFG
- TRR274(ID408885537)/DFG
- TRR355(ID490846870)/DFG
- EXC2145(ID390857198)/DFG
- TRR355/1(490846870)/DFG
- DZHK Excellence Programme
- Else-Kröner-Fresenius Foundation
- Hertie Network of Clinical Neuroscience
- Peter-Hans Hofschneider Foundation
- Physician-Scientist Programme of Heidelberg University
- University of Mainz (Inneruniversitäre Forschungsförderung)
- Ministry of Science Baden-Württemberg
- Munich Cluster for Systems Neurology
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous